The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)

Clinical trial NCT06291415 · WITHDRAWN

Trial details

NCT number: NCT06291415
Sponsor: Hutchmed
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Immune Thrombocytopenia Blood Platelet Disorder Hematologic Diseases Purpura, Thrombocytopenic Purpura Blood Coagulation Disorder Thrombotic Microangiopathies Hemorrhagic Disorders Autoimmune Diseases Immune System Diseases Hemorrhage Pathologic Processes

Start date: 2024-04-02
Primary completion: 2026-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.